top 20Cardiovascular metabolic system diseases

As a biotech solutions ltd, we will do our best to meet all the needs of customers.

 

If you want to know more about biotech solutions, please visit our website.

 

Youngen, based in Beijing, is a leading oligonucleotide therapeutic company built around AOC modality. Youngen has been dedicated to develop RNAi therapeutics to a broad spectrum of difficult-to-treat diseases, both rare and general, impacting millions of people and families around the world. Leveraging cutting-edge technological platforms, we build globally competitive diversified product pipelines with first-in-classband Best-in-class potentials.We are advancing programs across key therapeutic areas, including cardiovascular, renal, central nervous system (CNS), and metabolic diseases, to deliver novel treatment options for patients in need.

 

There are many biomedical companies, but we are one of the best choices for you.

 

 

 

Enjoyed this article? Stay informed by joining our newsletter!

Comments

You must be logged in to post a comment.

About Author

Youngen, based in Beijing, is a biotechnology company pioneering the development of next-generation siRNA drugs to silence specific mRNAs and reduce the production of proteins that cause disease. Youngen has been dedicating to bring RNAi therapeutics to a broad spectrum of difficult-to-treat diseases, both rare and general population impacting millions of people around the world. Leveraging these platform technologies, we built diversified product pipelines with globally competitive, first-in-class and best-in-class potential. We’re exploring many therapeutic areas to bring more treatment options to the patients with metabolic and cardiovascular diseases, immune-mediated diseases, and neurological disorders. https://www.youngenbiomed.com/

Recent Articles
Aug 18, 2026, 9:02 AM youngen
Aug 18, 2026, 8:53 AM honyemb
Aug 18, 2026, 8:52 AM honyemb